Literature DB >> 10943904

Persisting consequences of drug intake: towards a memory of addiction.

A Heyne1, T May, P Goll, J Wolffgramm.   

Abstract

Long-term intake of a psychoactive drug alters brain signal transduction, emotional and motivational factors and behavioral parameters. Some effects that outlast long periods of abstinence are due to the long-term presence of the drug in the organism (tolerance, physical dependence). Withdrawal symptoms, as a consequence of physical dependence, can be protracted, i.e. they persist after long periods of drug deprivation (e.g. a desensitization of the production of cAMP). Further persisting effects include experience-based learning. At least three distinct processes can be differentiated: a memory of drug effects (reflected by a sensitization to drug effects etc.), a memory of drug use (reflected by controlled drug consumption), and a memory of addiction (reflected by a persisting loss of control over drug intake and correlating changes in striatal dopaminergic neurotransmission). The latter probably consists of two components: a general memory of loss of control and a specific memory of the addictive drug (general principles for the development of addiction, specific of the urge for the addictive drug).

Entities:  

Mesh:

Year:  2000        PMID: 10943904     DOI: 10.1007/s007020070065

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  10 in total

1.  Aspects of the relationship between drug dose and drug effect.

Authors:  Abraham Peper
Journal:  Dose Response       Date:  2009-02-09       Impact factor: 2.658

2.  Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist.

Authors:  George R Breese; David H Overstreet; Darin J Knapp; Montserrat Navarro
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

Review 3.  Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis.

Authors:  George R Breese; David H Overstreet; Darin J Knapp
Journal:  Psychopharmacology (Berl)       Date:  2004-10-23       Impact factor: 4.530

4.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

Review 5.  Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment.

Authors:  Christian Jacob
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

Review 6.  The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.

Authors:  Balapal S Basavarajappa
Journal:  Mini Rev Med Chem       Date:  2007-08       Impact factor: 3.862

7.  Episodic memories and their relevance for psychoactive drug use and addiction.

Authors:  Christian P Müller
Journal:  Front Behav Neurosci       Date:  2013-05-23       Impact factor: 3.558

8.  Long-term alcohol drinking in High Drinking in the Dark mice is stable for many months and does not show alcohol deprivation effects.

Authors:  John C Crabbe; Wyatt R Hack; Angela R Ozburn; Antonia M Savarese; Pamela Metten
Journal:  Addict Biol       Date:  2021-07-05       Impact factor: 4.280

9.  Dissociating effects of cocaine and d-amphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats.

Authors:  M Pum; R J Carey; J P Huston; C P Müller
Journal:  Psychopharmacology (Berl)       Date:  2007-04-29       Impact factor: 4.415

10.  The AIP Model of EMDR Therapy and Pathogenic Memories.

Authors:  Michael Hase; Ute M Balmaceda; Luca Ostacoli; Peter Liebermann; Arne Hofmann
Journal:  Front Psychol       Date:  2017-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.